BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18763225)

  • 1. Choreatic symptoms during and after treatment with paliperidone and escitalopram.
    Hüther R; Gebhart C; Mirisch S; Bäuml J; Förstl H
    Pharmacopsychiatry; 2008 Sep; 41(5):203-4. PubMed ID: 18763225
    [No Abstract]   [Full Text] [Related]  

  • 2. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
    Park YM; Lee HJ; Kang SG; Choo CS; Cho JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):380-1. PubMed ID: 19121360
    [No Abstract]   [Full Text] [Related]  

  • 3. Paliperidone-induced leukopenia and neutropenia: a case report.
    Kim JN; Lee BC; Choi IG; Jon DI; Jung MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):284-5. PubMed ID: 20920543
    [No Abstract]   [Full Text] [Related]  

  • 4. Rabbit syndrome following discontinuation of paliperidone in a patient with schizoaffective disorder.
    Liang CS; Yang FW; Huang YC
    J Clin Psychopharmacol; 2012 Oct; 32(5):720-1. PubMed ID: 22926613
    [No Abstract]   [Full Text] [Related]  

  • 5. Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to paliperidone.
    Hsu WY; Chiu NY
    J Clin Psychopharmacol; 2013 Oct; 33(5):712-3. PubMed ID: 23899637
    [No Abstract]   [Full Text] [Related]  

  • 6. Paliperidone-induced mania-like symptoms: a case report.
    Wang WT; Chen CH; Lu ML; Lai TJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1351-2. PubMed ID: 20600461
    [No Abstract]   [Full Text] [Related]  

  • 7. Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression.
    Wand AP
    Aust N Z J Psychiatry; 2012 Feb; 46(2):178. PubMed ID: 22311539
    [No Abstract]   [Full Text] [Related]  

  • 8. Lower risk for body weight gain and better control of appetite after switching risperidone to paliperidone in a schizoaffective patient.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E36-7. PubMed ID: 24763786
    [No Abstract]   [Full Text] [Related]  

  • 9. Citalopram-associated spontaneous ejaculations.
    Virit O; Savas HA
    J Clin Psychopharmacol; 2008 Jun; 28(3):360-1. PubMed ID: 18480704
    [No Abstract]   [Full Text] [Related]  

  • 10. Manic symptoms induced by paliperidone.
    Hsieh CH; Liou YJ
    J Clin Psychopharmacol; 2010 Apr; 30(2):202-4. PubMed ID: 20520298
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose escitalopram-associated hyponatremia.
    Pae CU; Park GY; Im S; Ko SB; Lee SJ
    Asia Pac Psychiatry; 2013 Jun; 5(2):E90. PubMed ID: 23857817
    [No Abstract]   [Full Text] [Related]  

  • 12. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
    Teng PR; Lane HY
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327
    [No Abstract]   [Full Text] [Related]  

  • 13. Paliperidone-related rabbit syndrome.
    Teng PR; Lai TJ
    J Clin Psychopharmacol; 2011 Jun; 31(3):379-80. PubMed ID: 21532365
    [No Abstract]   [Full Text] [Related]  

  • 14. [Citalopram].
    Taéron C
    Rev Infirm; 2008 Nov; (145):47-9. PubMed ID: 19044198
    [No Abstract]   [Full Text] [Related]  

  • 15. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial.
    Chokka P; Legault M
    Depress Anxiety; 2008; 25(12):E173-81. PubMed ID: 19006260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.
    Han C; Lee SJ; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):650-1. PubMed ID: 21163319
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of Escitalopram-Induced Sweating With Citalopram.
    Kolli V; Rainville CT
    Prim Care Companion CNS Disord; 2017 Apr; 19(2):. PubMed ID: 28426928
    [No Abstract]   [Full Text] [Related]  

  • 19. Lactation associated with fluoxetine treatment.
    Arya DK; Taylor WS
    Aust N Z J Psychiatry; 1995 Dec; 29(4):697. PubMed ID: 8825840
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement in psychotic symptoms and social functioning after augmentation of paliperidone with clozapine in a patient with schizoaffective disorder.
    Hou YC
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):E26. PubMed ID: 24515699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.